Groep Brussel Lambert NV
XBER:EAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Groep Brussel Lambert NV
XBER:EAI
|
BE |
|
P
|
Procter & Gamble Co
XHAM:PRG
|
US |
|
A
|
Anglo American PLC
JSE:AGL
|
UK |
|
Amgen Inc
LSE:0R0T
|
US |
|
Sands China Ltd
F:599A
|
MO |
|
P
|
Pro Medicus Ltd
OTC:PMCUF
|
AU |
Wall St Price Targets
EAI Price Targets Summary
Groep Brussel Lambert NV
According to Wall Street analysts, the average 1-year price target for EAI is 90.91 EUR with a low forecast of 79.89 EUR and a high forecast of 98.82 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EAI's stock price target?
Price Target
90.91
EUR
According to Wall Street analysts, the average 1-year price target for EAI is 90.91 EUR with a low forecast of 79.89 EUR and a high forecast of 98.82 EUR.
What is the Revenue forecast for Groep Brussel Lambert NV?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Groep Brussel Lambert NV?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 9 years is -4%.
What is the Operating Income forecast for Groep Brussel Lambert NV?
Projected CAGR
79%
Over the last 13 years, the compound annual growth rate for Operating Income has been -12%. The projected CAGR for the next 2 years is 79%.
